Liquidia LQDA
NASDAQ LQDA
$71.57 -3.76 (-4.99%)
At close: Aug 20, 2026 · 7:09 PM UTC

Liquidia (LQDA) Return on Sales Growth (5y) (2025 - 2026)

Liquidia (LQDA) Return on Sales Growth (5y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.89 Bn 42.93 Bn -
2 Teva Pharmaceutical Industries 43.30 Bn 39.65 Bn 2.15 Bn
3 Zoetis 31.45 Bn 29.77 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.58 Bn 22.78 Bn 5.10 Bn
5 United Therapeutics 22.20 Bn 19.53 Bn 683.80 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn
7 Neurocrine Biosciences 15.50 Bn 15.11 Bn 935.80 Mn
8 Elanco Animal Health 11.70 Bn 11.17 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.12 Bn 9.96 Bn -
10 Liquidia 6.36 Bn 6.08 Bn 160.92 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 4.00
Mar 31, 2026 6.00
Dec 31, 2025 22.00